Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.
Neuro-Oncology|September 11, 2019
Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomasAurore Surun, Pascale Varlet, Laurence Brugières, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in NeuroblastomaMathieu Chicard, Sandrine Boyault, Leo Colmet Daage, et al.
BMC Cancer|May 14, 2017
A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programmeCharlotte Demoor-Goldschmidt, Delphine Drui, Isabelle Doutriaux, et al.
Pediatric Blood & Cancer|November 29, 2021
Lessons from a large nationwide cohort of 350 children with ovarian mature teratoma: A study in favor of ovarian-sparing surgeryFanny Delehaye, Sabine Sarnacki, Daniel Orbach, et al.
Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Pageof 8